Assessing muscle health in older adults
SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine
This study is testing different ways to check muscle health in older adults to see if it can help identify and manage muscle weakness and frailty better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University Department of Geriatric Medicine FELIX PLATTER Academic / other |
| Locations | 1 site (Basel) |
| Trial ID | NCT05263596 on ClinicalTrials.gov |
What this trial studies
This study focuses on diagnosing sarcopenia, muscle weakness, and frailty in older adults using various methods such as dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA). Participants aged 65 and older will undergo a series of assessments, including muscle strength measurements and nutritional evaluations, to determine their muscle mass and overall health status. The study aims to standardize the diagnostic process for sarcopenia and improve patient outcomes through better identification and management of this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 65 and older who are newly admitted to the hospital.
Not a fit: Patients who are bedridden, have a life expectancy of less than three months, or have certain implanted medical devices may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for sarcopenia, enhancing treatment strategies and outcomes for older patients.
How similar studies have performed: Other studies have shown success in using similar diagnostic approaches for sarcopenia, indicating that this methodology is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The investigators aim to include patients ≥ 65 years old newly admitted for study eligibility at the UAFP. Exclusion Criteria: * Lack of informed written consent * Implanted defibrillation device * Implanted pacemaker * Acute sepsis or severe volume overload * Life expectancy of \< 3 months according to treating doctor * bedridden * Plasters or bandages that cannot be removed from the feet or hands * Isolated patients (contact and aerosol) * Measurement is not possible due to organizational reasons * Inability to follow the procedures, e.g. due to language problems, psychological disorders
Where this trial is running
Basel
- Universitäre Altersmedizin Felix Platter — Basel, Switzerland (Recruiting)
Study contacts
- Principal investigator: Andreas M. Fischer — Universitäre Altersmedizin Felix Platter
- Study coordinator: Andreas M. Fischer
- Email: andreasmfischer.basel@gmail.com
- Phone: 0613265102
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.